Boston Scientific Preferred Stock, Shares Authorized remained flat by 0.0% to 50M in Q3 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from 50M to 50M. Over 4 years (FY 2020 to FY 2024), Preferred Stock, Shares Authorized shows relatively stable performance with a 0.0% CAGR.
other_preferred_stock_shares_authorized| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 50M | 50M | 50M | 50M | 50M | 50M | 50M | 50M | 50M | 50M | 50M | 50M | 50M | 50M | 50M | 50M | 50M | 50M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |